BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1390213)

  • 1. Platelet alloimmunization after multiple transfusions: a prospective study of 50 patients.
    Godeau B; Fromont P; Seror T; Duedari N; Bierling P
    Br J Haematol; 1992 Jul; 81(3):395-400. PubMed ID: 1390213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments:a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test.
    Kurz M; Knöbl P; Kalhs P; Greinix HT; Höcker P; Panzer S
    Transfusion; 2001 Jun; 41(6):771-4. PubMed ID: 11399818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
    Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
    Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of antibody response to human platelet transfusion.
    Wu KK; Thompson JS; Koepke JA; Hoak JC; Flink R
    J Clin Invest; 1976 Aug; 58(2):432-8. PubMed ID: 956376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-specific antibodies in transfused patients.
    Uhrynowska M; Zupańska B
    Eur J Haematol; 1996 Apr; 56(4):248-51. PubMed ID: 8641394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet alloimmunization after transfusion. A prospective study in 117 heart surgery patients.
    Taaning E; Simonsen AC; Hjelms E; Svejgaard A; Morling N
    Vox Sang; 1997; 72(4):238-41. PubMed ID: 9228715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and specificity of platelet-specific alloantibodies in HLA-immunized haematologic-oncologic patients.
    Schnaidt M; Northoff H; Wernet D
    Transfus Med; 1996 Jun; 6(2):111-4. PubMed ID: 8809957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
    Bajpai M; Kaura B; Marwaha N; Kumari S; Sharma RR; Agnihotri SK
    Natl Med J India; 2005; 18(3):134-6. PubMed ID: 16130614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of HLA and platelet-reactive antibodies in alloimmunized patients refractory to platelet therapy.
    Brubaker DB; Romine M
    Am J Hematol; 1987 Dec; 26(4):341-52. PubMed ID: 3687931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of 4 crossmatching methods for predicting the success of platelet transfusion].
    Santoso S; Kiefel V; Kühn J; Mueller-Eckhardt G; Mueller-Eckhardt C
    Beitr Infusionsther; 1990; 26():153-6. PubMed ID: 1703818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
    Basire A; Picard C
    Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoreactive platelet antibody in post transfusion purpura.
    Minchinton RM; Cunningham I; Cole-Sinclair M; Van der Weyden M; Vaughan S; McGrath KM
    Aust N Z J Med; 1990 Apr; 20(2):111-5. PubMed ID: 2188642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assays for the detection of human leucocyte antigen and human platelet antigen antibodies.
    Fontão-Wendel R; Silva LC; Saviolo CB; Primavera B; Wendel S
    Vox Sang; 2007 Oct; 93(3):241-9. PubMed ID: 17845262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric detection of platelet-reactive antibodies and application in platelet crossmatching.
    Köhler M; Dittmann J; Legler TJ; Lynen R; Humpe A; Riggert J; Neumeyer H; Pies A; Panzer S; Mayr WR
    Transfusion; 1996 Mar; 36(3):250-5. PubMed ID: 8604511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disappearance of HLA and platelet-specific antibodies in acute leukaemia patients alloimmunized by multiple transfusions.
    Murphy MF; Metcalfe P; Ord J; Lister TA; Waters AH
    Br J Haematol; 1987 Nov; 67(3):255-60. PubMed ID: 3689693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness.
    Saris A; Pavenski K
    Transfus Med Rev; 2020 Oct; 34(4):250-257. PubMed ID: 33127210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets.
    Rijkers M; Schmidt D; Lu N; Kramer CSM; Heidt S; Mulder A; Porcelijn L; Claas FHJ; Leebeek FWG; Jansen AJG; Jongerius I; Zeerleder SS; Vidarsson G; Voorberg J; de Haas M
    Haematologica; 2019 Feb; 104(2):403-416. PubMed ID: 30262558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
    Amemiya Y
    Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.